Industry appointments

Industry appointments

Olivier Cremoux to lead pharma, medical device for Stäubli Robotics North America; Stefan Steenstrup appointed president of Seco; Mahr appoints Manuel Hüsken as CEO


Mahr appoints Manuel Hüsken as CEO

Mahr Inc. officials announced that Manuel Hüsken has been appointed as the company’s new chief executive officer (CEO). After almost 30 years at Mahr, Stephan Gais leaves his post as CEO and joins the company’s advisory board.

Manuel previously served as the company’s CSO. In his new role as CEO, he will lead the executive board and will be responsible for group strategy, corporate communications, and direction of various business unit metrology departments. Together with his colleagues Udo Erath (COO) and Dr. Lutz Aschke (CFO/CIO), the board managers are responsible for implementing the Mahr Group’s strategy.



Stefan Steenstrup appointed president of Seco

© Seco |
Stefan Steenstrup

Stefan Steenstrup has been appointed president and CEO of Seco as of October 1, 2021, succeeding Fredrik Vejgården who decided to leave Seco to start his own business.

Steenstrup has been working for Sandvik for more than 20 years most recently serving as president of Dormer Pramet since 2017. Prior to that, he held various positions at Sandvik Machining Solutions (SMS), such as global sales director, business development manager, and product service manager.

Steenstrup holds a Master of Science in Mechanical Engineering from the Technical University of Denmark in Copenhagen. He is Danish, and is currently living in Milan, Italy with his family.

Steenstrup’s extensive experience and solid understanding of the machine tooling industry with a strong customer focus creates an excellent foundation to continue the growth of the Seco business around the world.



Olivier Cremoux to lead pharma, medical device for Stäubli Robotics North America

© Stäubli |
Olivier Cremoux

Stäubli announced that Olivier Cremoux has been appointed deputy head of pharma and medical device for Stäubli Robotics North America.

Cremoux joined Stäubli Group in 2015 before transferring to Stäubli Corp. as the north american business development manager for robotics in 2018. Most recently, he became key account manager – pharma and will maintain this role throughout the transition period.  Cremoux will use his experience to help build the Medical Robotics team while focusing on the pharma and medical device specific markets.

Cremoux graduated from the National Institute of Science Applied of Lyon (France) with a bachelor degree in Electrical Engineering.